Endeavour zotarolimus-eluting stent reduces stent thrombosis and improves clinical outcomes compared with cypher sirolimus-eluting stent: 4-year results of the PROTECT randomized trial

William Wijns, Ph. Gabriel Steg, Laura Mauri, Volkhard Kurowski, Keyur Parikh, Runlin Gao, Christoph Bode, John P. Greenwood, Erik Lipsic, Farqad Alamgir, Tessa Rademaker-Havinga, Eric Boersma, Peter Radke, Frank van Leeuwen, Edoardo Camenzind

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)2812-2820
JournalEuropean Heart Journal
Volume35
Issue number40
DOIs
Publication statusPublished - 21 Oct 2014

Keywords

  • Drug-eluting stent
  • Late stent thrombosis
  • Myocardial infarction
  • Endothelialization
  • Sirolimus
  • Zotarolimus

Cite this

Wijns, W., Steg, P. G., Mauri, L., Kurowski, V., Parikh, K., Gao, R., Bode, C., Greenwood, J. P., Lipsic, E., Alamgir, F., Rademaker-Havinga, T., Boersma, E., Radke, P., van Leeuwen, F., & Camenzind, E. (2014). Endeavour zotarolimus-eluting stent reduces stent thrombosis and improves clinical outcomes compared with cypher sirolimus-eluting stent: 4-year results of the PROTECT randomized trial. European Heart Journal, 35(40), 2812-2820. https://doi.org/10.1093/eurheartj/ehu318